Orion Corporation
在场
高管
查看带有其 19 名主要高管的组织结构图
Orion Corporation 搜索最多的简介
高管在Orion Corporation变化
- Olli Huotari, Senior Vice President, Corporate Functions, 将于 20245月30 退休 (新闻发布的2024五月8号).
- Virve Laitinen, Senior Vice President, Corporate Strategy and Program Management, 将于 20243月31 退休 (新闻发布的2024三月25号).
- Hilpi Rautelin 曾任 Director, 现升职为 Vice Chairman of the Board (新闻发布的2024三月21号).
创建提醒
跟踪 Orion Corporation 的高管变动
药店
Orion Corporation 拥有 1,837 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Grace Therapeutics将在Oct 24, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
- Orasis Pharmaceuticals 刚刚宣布为 78 筹款数百万美元。 (公布2024十月21号).
- Lundbeck has announced the acquisition of Longboard Pharmaceuticals (公布2024十月17号).
药店 行业的其他推荐联系人
消息
Orion Corporation 的最新新闻稿
- Privacy | Notified
- Newsroom
- Uutishuone
- Orion is building a unique pharmaceutical research ecosystem in Finland – using data and artificial intelligence to shorten the development time of new innovative medicines | Orion
- Orion and Bayer expand clinical development program for darolutamide in prostate cancer | Orion
- Darolutamide approved for additional prostate cancer indication in China | Orion
- Darolutamide receives EU approval for additional indication in prostate cancer | Orion
- Darolutamide receives approval for additional prostate cancer indication in Japan | Orion
- Save the date: Orion’s Capital Markets Day 2023 | Orion
- Positive CHMP opinion for darolutamide in combination with docetaxel for the treatment of metastatic hormone-sensitive prostate cancer | Orion
- View more press releases Close
关于 Orion Corporation 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Liisa Hurme 
